Stock listing
NASDAQ:ALIM Alimera Sciences Inc Stock
Follow Alimera Sciences Inc into a list and get an email when it puts out news.
Last close · NASDAQ:ALIM
$5.54 USD
Close on Sep 13, 2024 · No longer trades
- Lowest – highest close
- $1.35 – $11.35 USDSince Nov 15, 2019 · lowest Mar 22, 2023 · highest Mar 11, 2021
Delisted NASDAQ:ALIM no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:ALIM
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Alimera Sciences Inc on 6ix
- Calls
- 10 calls with a replay · 10 with a transcript · latest May 14, 2024
- Decks
- 23 decks · latest Jun 7, 2022
Events
| Call | When | Status |
|---|---|---|
| Alimera Sciences (ALIM) Q1 2024 Earnings Call | Tue, May 14, 2024 · 9:00 AM ET | Replay |
| Alimera Sciences (ALIM) Q4 2023 Earnings Call | Thu, Mar 07, 2024 · 9:00 AM ET | Replay |
| Alimera Sciences (ALIM) Q3 2023 Earnings Call | Thu, Oct 26, 2023 · 9:00 AM ET | Replay |
| Alimera Sciences (ALIM) Q2 2023 Earnings Call | Thu, Aug 10, 2023 · 9:00 AM ET | Replay |
| Alimera Sciences (ALIM) Q1 2023 Earnings Call | Thu, May 18, 2023 · 8:30 AM ET | Replay |
| Alimera Sciences (ALIM) Q4 2022 Earnings Call | Fri, Mar 31, 2023 · 9:00 AM ET | Replay |
| Alimera Sciences (ALIM) Q3 2022 Earnings Call | Mon, Nov 14, 2022 · 9:00 AM ET | Replay |
| Alimera Sciences (ALIM) Q2 2022 Earnings Call | Wed, Jul 27, 2022 · 9:00 AM ET | Replay |
| Alimera Sciences (ALIM) Q1 2022 Earnings Call | Mon, May 09, 2022 · 9:00 AM ET | Replay |
| Alimera Sciences (ALIM) Q4 2021 Earnings Call | Thu, Feb 24, 2022 · 9:00 AM ET | Replay |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Corporate Update (June 2022) | Corporate update | 20 slides | Jun 7, 2022 |
| Q4 2018 Earnings Presentation | Earnings | 13 slides | Feb 19, 2019 |
| Q3 2018 Earnings Presentation | Earnings | 10 slides | Nov 6, 2018 |
| Q2 2018 Earnings Presentation | Earnings | 11 slides | Jul 30, 2018 |
| Q1 2018 Earnings Presentation | Earnings | 13 slides | May 3, 2018 |
| Q3 2017 Earnings Presentation | Earnings | 16 slides | Nov 2, 2017 |
| Q2 2017 Earnings Presentation | Earnings | 12 slides | Aug 3, 2017 |
| Q1 2017 Earnings Presentation | Earnings | 22 slides | May 9, 2017 |
| FY2016 Earnings Presentation | Earnings | 13 slides | Mar 1, 2017 |
| Q3 2016 Earnings Presentation | Earnings | 12 slides | Nov 3, 2016 |
All 23 decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Q2 2016 Earnings Presentation | Earnings | 12 slides | Aug 4, 2016 |
| Cantor Fitzgerald's 2nd Annual Healthcare Conference 2016 | Conference | 20 slides | Jul 12, 2016 |
| Q1 2016 Earnings Presentation | Earnings | 13 slides | May 5, 2016 |
| Investor Presentation (March 2016) | Investor deck | 21 slides | Mar 8, 2016 |
| Q4 2015 Earnings Presentation | Earnings | 15 slides | Mar 3, 2016 |
| UBS Healthcare Conference (May 2015) | Conference | 28 slides | May 18, 2015 |
| Investor Day (March 2015) | Investor day | 67 slides | Mar 25, 2015 |
| Investor Day (July 2012) | Investor day | 54 slides | Jul 18, 2012 |
| Technical Presentation (August 2011) | Technical | 20 slides | Aug 25, 2011 |
| Technical Presentation (May 2011) | Technical | 15 slides | May 5, 2011 |
| Technical Presentation (May 2011) | Technical | 31 slides | May 3, 2011 |
| Technical Presentation (February 2011) | Technical | 25 slides | Feb 14, 2011 |
| Technical Presentation (February 2011) | Technical | 21 slides | Feb 3, 2011 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Russell Skibsted Other companies: Processa Pharmaceuticals, Inc. (Chief Financial Officer · Since at least Jul 16, 2024); Aeolus Pharmaceuticals Inc (Chief Financial Officer · Since at least May 23, 2012); Rockwell Medical, Inc. (See Remarks · Sep 15, 2020 – Sep 9, 2022 · Past); Serina Therapeutics, Inc. (Chief Financial Officer · Nov 27, 2018 – Dec 31, 2018 · Past); Insight Molecular Diagnostics Inc. (Chief Financial Officer · Dec 30, 2015 – Dec 30, 2015 · Past); Lineage Cell Therapeutics, Inc. (Chief Financial Officer · Nov 16, 2015 – Dec 18, 2018 · Past) | Chief Financial Officer & SVP · Jan 9, 2023 – Nov 21, 2023 · Past |
| Garheng Kong Other companies: Xeris Biopharma Holdings, Inc. (Director · Since at least Oct 5, 2021); Labcorp Holdings Inc. (Director · Since at least Feb 4, 2020); Venus Concept Inc (Director · Nov 7, 2019 – Mar 24, 2023 · Past); Strongbridge Biopharma plc (Director · May 15, 2019 – Oct 5, 2021 · Past) | Director · Jun 19, 2019 – Jan 4, 2023 · Past |
| Michael Kaseta Other companies: Heron Therapeutics, Inc. (Director · Since at least Nov 4, 2024); Liquidia Corporation (CFO and COO · Since at least Nov 30, 2020); Aralez Pharmaceuticals Inc (Chief Financial Officer · Nov 30, 2017 – Mar 15, 2018 · Past) | Director · Mar 24, 2023 – Sep 16, 2024 · Past |
| Brian K Halak Other companies: Dicerna Pharmaceuticals Inc (Director · Jan 29, 2014 – Nov 2, 2018 · Past) | Director · Jun 18, 2013 – Jan 4, 2023 · Past |
| Calvin W Roberts Other companies: IVERIC bio Inc (Director · Jan 1, 2019 – Jul 11, 2023 · Past) | Director · Jun 18, 2013 – Jun 19, 2018 · Past |
| Erin Parsons Other companies: Kiora Pharmaceuticals, Inc. (Director · Since at least Mar 3, 2023) | Director · Jan 4, 2023 – Sep 16, 2024 · Past |
| Todd Michael Wood Other companies: Constellation Alpha Capital Corp (Chief Commercial Officer · Aug 29, 2019 – Jun 12, 2023 · Past) | President of U.S. Operations · Dec 11, 2023 – Sep 16, 2024 · Past |
| David Holland | Chief Marketing Officer & SVP · Nov 21, 2023 – Sep 16, 2024 · Past |
| Peter J Pizzo III | Director · Jun 14, 2012 – Sep 16, 2024 · Past |
| Philip Ashman | President of Int'l Operations · Jan 4, 2016 – Sep 16, 2024 · Past |
All 11 people
| Person | Seat |
|---|---|
| Samer Kaba | Chief Medical Officer · Apr 4, 2019 – Jan 7, 2021 · Past |
Log in to ask 6ix AI your own questions about Alimera Sciences Inc.